全文获取类型
收费全文 | 2502891篇 |
免费 | 179077篇 |
国内免费 | 8468篇 |
专业分类
耳鼻咽喉 | 32641篇 |
儿科学 | 79334篇 |
妇产科学 | 65849篇 |
基础医学 | 342353篇 |
口腔科学 | 66288篇 |
临床医学 | 223156篇 |
内科学 | 492307篇 |
皮肤病学 | 56353篇 |
神经病学 | 201607篇 |
特种医学 | 104461篇 |
外国民族医学 | 472篇 |
外科学 | 385636篇 |
综合类 | 53060篇 |
现状与发展 | 8篇 |
一般理论 | 728篇 |
预防医学 | 192744篇 |
眼科学 | 54881篇 |
药学 | 184363篇 |
10篇 | |
中国医学 | 6615篇 |
肿瘤学 | 147570篇 |
出版年
2021年 | 19391篇 |
2018年 | 45273篇 |
2017年 | 35511篇 |
2016年 | 41478篇 |
2015年 | 29109篇 |
2014年 | 39021篇 |
2013年 | 55869篇 |
2012年 | 78282篇 |
2011年 | 94512篇 |
2010年 | 62605篇 |
2009年 | 53823篇 |
2008年 | 86129篇 |
2007年 | 92063篇 |
2006年 | 74222篇 |
2005年 | 72650篇 |
2004年 | 70369篇 |
2003年 | 68520篇 |
2002年 | 63674篇 |
2001年 | 114449篇 |
2000年 | 117847篇 |
1999年 | 98310篇 |
1998年 | 28009篇 |
1997年 | 24814篇 |
1996年 | 25393篇 |
1995年 | 24969篇 |
1994年 | 23040篇 |
1993年 | 21624篇 |
1992年 | 78033篇 |
1991年 | 75688篇 |
1990年 | 73447篇 |
1989年 | 70431篇 |
1988年 | 64524篇 |
1987年 | 63196篇 |
1986年 | 59582篇 |
1985年 | 56926篇 |
1984年 | 42465篇 |
1983年 | 35758篇 |
1982年 | 21367篇 |
1981年 | 18914篇 |
1979年 | 38142篇 |
1978年 | 26888篇 |
1977年 | 23275篇 |
1976年 | 20884篇 |
1975年 | 22533篇 |
1974年 | 26367篇 |
1973年 | 25319篇 |
1972年 | 23694篇 |
1971年 | 21986篇 |
1970年 | 20167篇 |
1969年 | 19134篇 |
排序方式: 共有10000条查询结果,搜索用时 1 毫秒
961.
C K Fischer 《The Journal of reproductive medicine》1991,36(1):74-76
Fifteen cases of microtuboplasty were done as outpatient procedures at low cost and with increased patient convenience. Advances in outpatient surgery at free-standing surgery centers have allowed many new patient care innovations, and microsurgery should now be considered an outpatient procedure for gynecologic patients. Outpatient microtuboplastic surgery is not only feasible but perhaps preferable to that done as an inpatient procedure. 相似文献
962.
Hitoshi Tajiri M.D Kosuke Kozaiwa M.D Tokuzo Harada M.D Yoshikazu Ozaki M.D Kazunori Miki M.D Kazuo Shimizu M.D Shintaro Okada M.D. 《Pediatrics international》1991,33(3):323-326
We assessed the efficacy of a government-sponsored mass protection program in Osaka, Japan, for perinatal HBV infection in infants born to HBeAg positive HBV carrier mothers. We also evaluated the impact of optional follow-up procedures in such infants, including an evaluation of anti-HBs response and a booster dose of HBV vaccine for poor responders. The results demonstrated that this mass protection program protected 94.4% of the infants from perinatal HBV infection in the Osaka area. However, the proportion of infants with an unprotective level of anti-HBs was higher in the standard group than in the follow-up group both at 1.0 and 1.5 years of age, which was also the case for HBV events. Furthermore, the present study showed that a booster dose of vaccine in poor responders was very effective in promoting an anti-HBs response. In conclusion, we recommend that a follow-up blood test to confirm a response of anti-HBs to HBV vaccine should be performed at 4–8 weeks after the third injection of HBV vaccine in infants born to HBeAg positive HBV carrier mothers. We also recommend that a booster injection of HBV vaccine should be immediately given to poor responding infants who otherwise are at a considerable risk of developing HBV infection in late infancy. 相似文献
963.
964.
965.
T. A. Creagh P. A. McLean M. G. Donovan J. J. Walshe D. M. Murphy 《Transplant international》1993,6(1):39-41
Reluctance to use kidneys from older donors (>50 years of age) is based on reports of inferior results. We reviewed our experience with 45 kidneys transplanted from older donors. Primary nonfunction, immediate graft function, and 1-, 2- and 3-year graft survival rates were similar to those obtained with kidneys transplanted from donors aged between 20 and 40 years. Renal function at 1 year (as measured by serum creatinine) was poorer in kidneys from older donors. No beneficial effect with respect to graft survival was noted with cyclosporin therapy compared to conventional immunosuppression; however, the numbers are small. We conclude that kidneys from older donors are a valuable source for transplantation. 相似文献
966.
PHILLIPS D.I.W.; COOPER C.; FALL C.; PRENTICE L.; OSMOND C.; BARKER D.J.P.; SMITH B. REES 《QJM : monthly journal of the Association of Physicians》1993,86(4):247-253
To determine whether fetal and infant growth could influencesusceptibility to autoimmune disease in adults, the occurrenceof thyroid autoantibodies and autoimmune thyroiditis was studiedin 305 women, aged 6071, born in Hertfordshire and forwhom details of birth weight, infant growth, and feeding wereroutinely recorded. Thyroglobulin autoantibody was detectedin 37% of the women, thyroid peroxidase autoantibody in 41%,and autoimmune thyroiditis, defined as biochemical or clinicalhypothyroidism in association with thyroid autoantibodies, in5.6%. The proportion of women with thyroglobulin and thyroidperoxidase auto antibodies fell with increasing birth weightbut was not related to weight at 1 year of age or the methodof infant feeding. The prevalence of both autoantibodies rosewith increasing adult body mass index but fell as the waistto hip ratio increased. These results demonstrate the importance of early environmentin determining the susceptibility to autoimmune thyroid disease.The contrasting effects of adult body mass index and waist tohip ratio on antibody prevalence could be explained by theirassociations with different hormonal environments. 相似文献
967.
D.-Y. LIN I.-S. SHEEN C.-M. CHU & Y.-F. LIAW 《Alimentary pharmacology & therapeutics》1996,10(6):961-966
Background : The clinical course of chronic hepatitis B is variable. Patients with hepatic decompensation, bridging necrosis or an alpha-fetoprotein level greater than 100 ng/mL during an exacerbation of hepatitis have a high risk of developing cirrhosis. This study was conducted to evaluate the effect of colchicine in the prevention of cirrhosis in such patients.
Methods : Patients with risk factor(s) were randomized to receive either colchicine 5 mg/week or no specific treatment, the end point being development of cirrhosis.
Results : After a follow up period of 4 years, the treatment group had a marked reduction in exacerbations of acute hepatitis (32% vs. 63%/patient/year, P <0.005). Seven out of 38 patients in the treatment group and 10 out of 27 patients in the control group developed cirrhosis. The calculated cumulative incidence of cirrhosis by the end of first, second, third and fourth years in the treatment group was 8.7, 18.6, 32 and 32%, respectively. The corresponding figures in the control group were 30, 35.5, 46.3 and 73.2%, respectively, with a P -value of 0.057.
Conclusions : The results suggest that colchicine may prevent cirrhosis in chronic hepatitis B patients with risk factor(s), possibly by suppressing exacerbations of hepatitis through an anti-inflammatory effect. 相似文献
Methods : Patients with risk factor(s) were randomized to receive either colchicine 5 mg/week or no specific treatment, the end point being development of cirrhosis.
Results : After a follow up period of 4 years, the treatment group had a marked reduction in exacerbations of acute hepatitis (32% vs. 63%/patient/year, P <0.005). Seven out of 38 patients in the treatment group and 10 out of 27 patients in the control group developed cirrhosis. The calculated cumulative incidence of cirrhosis by the end of first, second, third and fourth years in the treatment group was 8.7, 18.6, 32 and 32%, respectively. The corresponding figures in the control group were 30, 35.5, 46.3 and 73.2%, respectively, with a P -value of 0.057.
Conclusions : The results suggest that colchicine may prevent cirrhosis in chronic hepatitis B patients with risk factor(s), possibly by suppressing exacerbations of hepatitis through an anti-inflammatory effect. 相似文献
968.
969.
970.
Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. 总被引:11,自引:6,他引:5
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
S. W. Chensue K. S. Warmington N. W. Lukacs P. M. Lincoln M. D. Burdick R. M. Strieter S. L. Kunkel 《The American journal of pathology》1995,146(1):130-138
The present study explored the role of murine monocyte chemotactic protein (MCP) in the T cell-mediated hypersensitive granulomatous response to Schistosoma mansoni eggs. The study examined the time course of local production, contribution to cellular infiltration, and the role of T cells in endogenous regulation. Synchronized pulmonary granulomas were induced under conditions of primary and secondary states of immunity. Primer-directed polymerase chain reaction analysis showed increased MCP mRNA expression in granulomatous lungs, mainly in the secondary response. Levels of MCP were measured by enzyme-linked immunosorbent assay in cultures of intact granulomas. Spontaneous MCP production was modest in primary granuloma cultures, reaching a maximum of 5.7 +/- 0.9 ng/ml by 16 days. In contrast, the secondary response showed augmented and accelerated production, achieving 13 +/- 2.0 ng/ml by 2 days. Immunohistochemical staining revealed the strongest MCP expression within microvascular adventitial cells or pericytes as well as in scattered mononuclear cells associated with granulomas. Staining was not detected in normal lungs. Passive immunization with anti-MCP-1 antibodies caused a 40% reduction in the secondary granuloma area but did not significantly affect the primary response. With adoptive cell transfer and T cell subset depletion, it was shown that Thy-1+ and CD5+ cells augmented, whereas CD8+ cells appeared to impair, MCP production. This provides direct evidence that MCP is involved in secondary Th2-mediated response to schistosome eggs and is subject to regulation by T cells. 相似文献